Dendreon fraught with challenges faced by Provenge
INDIANAPOLIS (AP): With a 60% plummet in Dendreon’s shares on Thursday, industry analysts revealed that Provenge, the company’s only marketed
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine